SECOND AMENDED AND RESTATED LICENSE AGREEMENT BY AND BETWEEN METSERA, INC., AND D&D PHARMATECH INC. Dated March 15, 2024License Agreement • January 10th, 2025 • Metsera, Inc. • Pharmaceutical preparations • New York
This SECOND AMENDED AND RESTATED LICENSE AGREEMENT (this “Agreement”) is dated as of March 15, 2024 (the “Effective Date”) by and between Metsera, Inc., a corporation organized under the laws of the State of Delaware having an address at 1200 Morris Turnpike, Suite 3005, Short Hills, NJ 07078, USA (“Metsera”) and D&D Pharmatech Inc., a corporation organized and existing under the laws of the Republic of Korea with a place of business at 4th Floor, 24, Pangyo-ro 255beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, (13486) Rep. of Korea (“D&D”). Metsera and D&D are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
LICENSE AGREEMENT BY AND BETWEEN METSERA, INC., AND D&D PHARMATECH INC. Dated March 15, 2024License Agreement • January 10th, 2025 • Metsera, Inc. • Pharmaceutical preparations • New York
This LICENSE AGREEMENT (this “Agreement”) is dated as of March 15, 2024 (the “Effective Date”) by and between Metsera, Inc., a corporation organized under the laws of the State of Delaware having an address at 1200 Morris Turnpike, Suite 3005, Short Hills, NJ 07078, USA (“Metsera”) and D&D Pharmatech Inc., a corporation organized and existing under the laws of the Republic of Korea with a place of business at 4th Floor, 24, Pangyo-ro 255beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, (13486) Rep. of Korea (“D&D”). Metsera and D&D are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
SECOND AMENDED AND RESTATED LICENSE AGREEMENT BY AND BETWEEN METSERA, INC., AND D&D PHARMATECH INC. Dated March 15, 2024License Agreement • December 12th, 2024 • Metsera, Inc. • Pharmaceutical preparations • New York
This SECOND AMENDED AND RESTATED LICENSE AGREEMENT (this “Agreement”) is dated as of March 15, 2024 (the “Effective Date”) by and between Metsera, Inc., a corporation organized under the laws of the State of Delaware having an address at 1200 Morris Turnpike, Suite 3005, Short Hills, NJ 07078, USA (“Metsera”) and D&D Pharmatech Inc., a corporation organized and existing under the laws of the Republic of Korea with a place of business at 4th Floor, 24, Pangyo-ro 255beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, (13486) Rep. of Korea (“D&D”). Metsera and D&D are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
LICENSE AGREEMENT BY AND BETWEEN METSERA, INC., AND D&D PHARMATECH INC. Dated March 15, 2024License Agreement • December 12th, 2024 • Metsera, Inc. • Pharmaceutical preparations • New York
This LICENSE AGREEMENT (this “Agreement”) is dated as of March 15, 2024 (the “Effective Date”) by and between Metsera, Inc., a corporation organized under the laws of the State of Delaware having an address at 1200 Morris Turnpike, Suite 3005, Short Hills, NJ 07078, USA (“Metsera”) and D&D Pharmatech Inc., a corporation organized and existing under the laws of the Republic of Korea with a place of business at 4th Floor, 24, Pangyo-ro 255beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, (13486) Rep. of Korea (“D&D”). Metsera and D&D are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”